After completing my postdoctoral fellowship from Genentech foundation in nuclear receptor pharmacology at the Salk Institute in La Jolla, I joined the Immunology Discovery department as a scientist and group leader. My team’s overarching goal is to leverage cutting edge biotechnology platforms to understand the molecular mechanisms governing fibroinflammatory diseases and translate these insights into potential therapies for human patients.
Genentech’s postdoctoral research program offers a highly collaborative environment for postdocs to perform translational and basic research that can be directly relevant to human diseases.
Cell Metabolism. 34 (9), 1377-1393.e8.
My group has been focusing on two research areas: